Support for

Healthcare Organisations

At Lilly, we value partnerships. Through working together, we can discover, develop, and deliver the innovative pharmaceutical therapies that will help people live longer, healthier, and more active lives. 

Lilly is committed to working with Europe-based patient advocacy organisations for the benefit of patients in a way that is true to the EFPIA Code of Practice and Lilly's integrity in business policy. Lilly takes its commitment to transparency seriously. Since 2009, Lilly has  published an annual register of Europe-based patient groups that have received either financial or significant non-financial support from Lilly.

  • To view details of the financial or significant non-financial support that Lilly has provided to  European-based patient organisations, please visit our European site at
  • Payment to Healthcare Organisations are published via a centralised industry website,,  from June 2016.  Lilly has also been publishing this data in the UK since 2012.
  • To view details of Lilly's partnership working with the NHS, please click here
  • For information on Lilly's Grants and Donations application process, please click here.

Eli Lilly and Company's disclosure of its support to patient organisations is one of the activities undertaken by the Company to improve transparency concerning Company dealings with third parties. Most of the data had to be compiled manually across a number of legal entities and countries. Eli Lilly and Company herein declares that the Company has made its best efforts to make a comprehensive disclosure of concerned activities.